Page last updated: 2024-10-21

(alpha-carboxycyclopropyl)glycine and Neuromuscular Diseases

(alpha-carboxycyclopropyl)glycine has been researched along with Neuromuscular Diseases in 1 studies

(alpha-carboxycyclopropyl)glycine: structure given in first source; glutamate receptor agonist

Neuromuscular Diseases: A general term encompassing lower MOTOR NEURON DISEASE; PERIPHERAL NERVOUS SYSTEM DISEASES; and certain MUSCULAR DISEASES. Manifestations include MUSCLE WEAKNESS; FASCICULATION; muscle ATROPHY; SPASM; MYOKYMIA; MUSCLE HYPERTONIA, myalgias, and MUSCLE HYPOTONIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shinozaki, H1

Other Studies

1 other study available for (alpha-carboxycyclopropyl)glycine and Neuromuscular Diseases

ArticleYear
Neuron damage induced by some potent kainoids and neuroprotective action of new agonists for metabotropic glutamate receptors.
    European neurology, 1994, Volume: 34 Suppl 3

    Topics: Amino Acids, Dicarboxylic; Animals; Animals, Newborn; Brain; Culture Techniques; Cyclopropanes; Dose

1994